Fields of application
A large number of pharmacological studies have been conducted with ginkgo leaves, their extract and individual ingredients. They have been proven to promote blood circulation in the brain, prevent damage from free radicals, improve memory and slow down the progression of Alzheimer’s disease. Due to its blood circulation-promoting effect, ginkgo is also suitable for the treatment of venous diseases. Areas of application: in Europe ginkgo extracts have been available in pharmacies for about four decades.
- Brain-organic performance disorder (dementia, Alzheimer’s disease)
- Concentration Disorder
- Depressive DisgruntlementDepression
- Swindle
- Tinnitus
- Headaches
- Peripheral arterial circulatory disorders (PAVK)
- Venous DiseaseVascular Veins
Effect
The reason for the positive effect on humans is probably the high concentration of flavonoids and terpenoids. The latter are in special form (Ginkolide and Bilobalide) only always found in Ginkgo Ginkgo. Some of these substances are so complex that it has not yet been possible to produce them synthetically to their full extent.In today’s medicine, the ginkgo is primarily said to have a blood circulation-promoting effect.
It is often administered to strengthen the brain. More recent studies investigate the effectiveness of ginkgo in protecting against arteriosclerosis (arterial calcification). The following effects have been experimentally proven: A positive effect of the above described effects can only be expected after an intake period of several weeks.
- Increasing the tolerance of the higher tissues to oxygen deficiency.
- Promotion of the brain blood circulation.
- Improvement of the flow properties of blood (rheology)
- Inhibition of the aggregation (sticking) of blood platelets.
- Influence on central neurotransmitters.
- In activation of harmful free radicals.
Dosage and application
Only extracts from the ginkgo leaves are used, which are produced according to special manufacturing processes, whereby an enrichment of the ingredients, which must be considered for the ineffective principle, must take place. Substances that are known to cause side effects are removed. For the treatment of brain-organic performance disorders (dementia), 120 to 240 mg dry extract daily divided into two or three single doses is recommended.
For the treatment of circulatory disorders or circulatory disorders of the inner ear, 120 to 160 mg dry extract divided into two or three single doses daily is recommended. Depending on the disease, a different duration of treatment is necessary and an effective onset can be expected. In the case of brain disorders (dementia), a treatment period of at least eight weeks is required.
After a treatment period of three months it should be checked whether the therapy was successful and should be continued. An improvement of arterial circulatory disorders can be expected after six weeks at the earliest. Scientific studies have shown that in the case of circulatory disorders of the inner ear, which can cause dizziness and tinnitus, a treatment period of more than six to eight weeks no longer brings any demonstrable benefit.
